SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-102562
Filing Date
2021-03-31
Accepted
2021-03-31 17:31:56
Documents
4
Effectiveness Date
2021-03-31

Document Format Files

Seq Description Document Type Size
1 S-8 d167330ds8.htm S-8 47910
2 EX-5.1 d167330dex51.htm EX-5.1 6379
3 EX-23.1 d167330dex231.htm EX-23.1 1978
4 GRAPHIC g167330dsp5.jpg GRAPHIC 4357
  Complete submission text file 0001193125-21-102562.txt   63448
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254936 | Film No.: 21794859
SIC: 2836 Biological Products, (No Diagnostic Substances)